Accelerating Antibody Development with Automated Octet Assays

Drug development and production is challenging, however, high throughput characterization systems can greatly accelerate discovery programs.

Using a proprietary discovery and development platform technology, Avitide enables its partners to rapidly advance candidate molecules to the clinic and achieve faster and more predictable bioprocess development timelines.

Download this whitepaper to discover the key considerations for automated Octet assays.